Startup aims to disrupt asthma, COPD space with digital inhaler

Formed just two years ago, pharma startup Pneuma Respiratory is developing a digital inhaler that it touts as the first of its kind. The company is looking to bring its technology to the more than 40 million people who suffer from asthma or chronic obstructive pulmonary disease in the U.S. They’re stepping into a highly competitive market, largely dominated by companies like GlaxoSmithKline (NYSE:GSK) and Merck (NYSE:MRK). Get the full story at our sister site, Drug Delivery Business News. The post Startup aims to disrupt asthma, COPD space with digital inhaler appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations mHealth (Mobile Health) Pharma Pharmaceuticals Respiratory GlaxoSmithKline plc Merck Pfizer pneumarespiratory Source Type: news